A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

October 3, 2024

Study Completion Date

December 18, 2024

Conditions

Healthy

Interventions

DRUG

Zongertinib

DRUG

Dabigatran-etexilate

DRUG

Rosuvastatin

DRUG

Metformin hydrochloride

DRUG

Furosemide

Trial Locations (1)

Humanpharmakologisches Zentrum Biberach, Biberach